Clinical Trials for Shionogi

A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls

A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment

Phase 1 Study of BPN14770 in Participants With Hepatic Impairment and Healthy Controls

Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS])

Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea

An Exploratory Clinical Study of a Low-dose Buprenorphine Patch for the Treatment of Autism Spectrum Disorders

A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants

Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID

P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants

A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids

S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

Olorofim Aspergillus Infection Study

DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr